ALX Oncology
CA - South SF
BiotechnologyFocus: Immuno-oncology
ALX Oncology is a life sciences company focused on Immuno-oncology.
Oncology
Open Jobs
0
Pipeline & Clinical Trials
Evorpacept
Metastatic CancerClinical Trials (1)
NCT03013218A Study of Evorpacept (ALX148) in Patients With Advanced Solid Tumors and Lymphoma (ASPEN-01)
Phase 1Phase 1
Clinical Trials (1)
NCT07085091A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
Phase 1evorpacept
Acute Myeloid LeukemiaClinical Trials (1)
NCT04755244A Study of Evorpacept (ALX148) With Venetoclax and Azacitidine for Acute Myeloid Leukemia (ASPEN-05)
Phase 1Evorpacept
Bladder CancerClinical Trials (1)
NCT05524545A Study of Evorpacept (ALX148) With Enfortumab Vedotin for Subjects With Urothelial Carcinoma (ASPEN-07)
Phase 1evorpacept
Higher Risk Myelodysplastic SyndromesClinical Trials (1)
NCT04417517A Study of Evorpacept (ALX148) With Azacitidine for Higher Risk Myelodysplastic Syndrome (ASPEN-02)
Phase 1Evorpacept
Breast Cancer, MetastaticClinical Trials (1)
NCT07007559ASPEN-09: A Study of Evorpacept in Combination With Anti-cancer Therapies in Advanced / Metastatic Malignancies
Phase 1/2Zanidatamab
HER2-expressing CancersClinical Trials (1)
NCT05027139A Study of Zanidatamab (ZW25) With Evorpacept (ALX148) in Patients With Advanced HER2-expressing Cancer
Phase 1/2evorpacept
Head and Neck CancerPembrolizumab
Ovarian CancerPhase 2
evorpacept
Head and Neck CancerEvorpacept
Gastric CancerOpen Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Portfolio: 7 clinical trials